181 related articles for article (PubMed ID: 18566446)
1. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands.
Muixí L; Carrascal M; Alvarez I; Daura X; Martí M; Armengol MP; Pinilla C; Abian J; Pujol-Borrell R; Jaraquemada D
J Immunol; 2008 Jul; 181(1):795-807. PubMed ID: 18566446
[TBL] [Abstract][Full Text] [Related]
2. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
Muixí L; Alvarez I; Jaraquemada D
Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
[TBL] [Abstract][Full Text] [Related]
3. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
[TBL] [Abstract][Full Text] [Related]
4. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
5. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.
Jacobson EM; Huber A; Tomer Y
J Autoimmun; 2008; 30(1-2):58-62. PubMed ID: 18178059
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis.
Flynn JC; McCormick DJ; Brusic V; Wan Q; Panos JC; Giraldo AA; David CS; Kong YC
Cell Immunol; 2004 Jun; 229(2):79-85. PubMed ID: 15474522
[TBL] [Abstract][Full Text] [Related]
7. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
[TBL] [Abstract][Full Text] [Related]
8. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
Zhang H; Li D; Ouyang A
Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
[TBL] [Abstract][Full Text] [Related]
9. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
10. Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.
Jacobson EM; Yang H; Menconi F; Wang R; Osman R; Skrabanek L; Li CW; Fadlalla M; Gandhi A; Chaturvedi V; Smith EP; Schwemberger S; Osterburg A; Babcock GF; Tomer Y
J Biol Chem; 2009 Dec; 284(49):34231-43. PubMed ID: 19776016
[TBL] [Abstract][Full Text] [Related]
11. [Circulating HLA-DR (Ia) positive T cells and T cell activation by thyroglobulin, thyroid microsome and TSH-receptor in autoimmune thyroid diseases].
Zeki K; Fujihira T; Shirakawa F; Watanabe K; Eto S
Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):719-26. PubMed ID: 3499354
[TBL] [Abstract][Full Text] [Related]
12. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
[TBL] [Abstract][Full Text] [Related]
13. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor.
Benvenga S; Santarpia L; Trimarchi F; Guarneri F
Thyroid; 2006 Mar; 16(3):225-36. PubMed ID: 16571084
[TBL] [Abstract][Full Text] [Related]
14. Tg.2098 is a major human thyroglobulin T-cell epitope.
Menconi F; Huber A; Osman R; Concepcion E; Jacobson EM; Stefan M; David CS; Tomer Y
J Autoimmun; 2010 Aug; 35(1):45-51. PubMed ID: 20303712
[TBL] [Abstract][Full Text] [Related]
15. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
Piccinini LA; Goldsmith NK; Schachter BS; Davies TF
J Clin Endocrinol Metab; 1988 Jun; 66(6):1307-15. PubMed ID: 2453529
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
Kissonerghis AM; Grubeck-Loebenstein B; Pirich K; Feldmann M; Londei M
Autoimmunity; 1989; 4(4):255-66. PubMed ID: 2518829
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR binding analysis of peptides from islet antigens in IDDM.
Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
[TBL] [Abstract][Full Text] [Related]
18. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.
Kong YC; Brown NK; Flynn JC; McCormick DJ; Brusic V; Morris GP; David CS
J Autoimmun; 2011 Sep; 37(2):63-70. PubMed ID: 21683551
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
